May 8, 2018 / 11:38 AM / 2 months ago

BRIEF-TG Therapeutics Reports Qtrly Loss Per Share Of $0.59

May 8 (Reuters) - TG Therapeutics Inc:

* TG THERAPEUTICS, INC. PROVIDES BUSINESS UPDATE AND REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

* CASH, CASH EQUIVALENTS, INVESTMENT SECURITIES, AND INTEREST RECEIVABLE WERE $109.2 MILLION AS OF MARCH 31, 2018

* QTRLY LOSS PER SHARE $0.59

* Q1 EARNINGS PER SHARE VIEW $-0.44 -- THOMSON REUTERS I/B/E/S

* TG THERAPEUTICS-CASH, CASH EQUIVALENTS, INVESTMENT SECURITIES, INTEREST RECEIVABLE ON HAND AS OF MARCH 31, SUFFICIENT TO FUND OPERATIONS THROUGH MID-2019 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below